bromodeoxyuridine has been researched along with Folic Acid Deficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, J; Blair, IA; Hammons, AL; Jochems, J; Summers, CM; Whitehead, AS; Zhang, S | 1 |
| Li, D; Rozen, R | 1 |
2 other study(ies) available for bromodeoxyuridine and Folic Acid Deficiency
| Article | Year |
|---|---|
Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells.
Topics: Antimetabolites, Antineoplastic; Atherosclerosis; Bromodeoxyuridine; Cell Line; Cell Proliferation; Cell Survival; Folic Acid; Folic Acid Antagonists; Folic Acid Deficiency; Gene Expression; Humans; Inflammation; Methotrexate; Phenotype | 2014 |
Maternal folate deficiency affects proliferation, but not apoptosis, in embryonic mouse heart.
Topics: Animals; Antimetabolites; Apoptosis; Bromodeoxyuridine; Cell Proliferation; Diet; Embryonic Development; Female; Folic Acid; Folic Acid Deficiency; Genotype; Heart Defects, Congenital; Hematinics; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Pregnancy | 2006 |